substance p (6-11), arg(6)-trp(7,9)-me-phe(8)- has been researched along with arginine vasopressin in 1 studies
| Studies (substance p (6-11), arg(6)-trp(7,9)-me-phe(8)-) | Trials (substance p (6-11), arg(6)-trp(7,9)-me-phe(8)-) | Recent Studies (post-2010) (substance p (6-11), arg(6)-trp(7,9)-me-phe(8)-) | Studies (arginine vasopressin) | Trials (arginine vasopressin) | Recent Studies (post-2010) (arginine vasopressin) |
|---|---|---|---|---|---|
| 20 | 0 | 1 | 12,278 | 422 | 1,212 |
| Protein | Taxonomy | substance p (6-11), arg(6)-trp(7,9)-me-phe(8)- (IC50) | arginine vasopressin (IC50) |
|---|---|---|---|
| Vasopressin V2 receptor | Homo sapiens (human) | 0.242 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haslett, C; MacKinnon, AC; Rossi, AG; Seckl, M; Sethi, T; Tufail-Hanif, U; Wheatley, M | 1 |
1 other study(ies) available for substance p (6-11), arg(6)-trp(7,9)-me-phe(8)- and arginine vasopressin
| Article | Year |
|---|---|
Targeting V1A-vasopressin receptors with [Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) identifies a strategy to develop novel anti-cancer therapies.
Topics: Animals; Antineoplastic Agents; Arginine Vasopressin; Calcium; Carcinoma, Small Cell; Cell Line, Tumor; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; Extracellular Signal-Regulated MAP Kinases; Humans; Lung Neoplasms; Peptide Fragments; Pertussis Toxin; Receptors, Bombesin; Receptors, Vasopressin; Signal Transduction; Substance P; Type C Phospholipases | 2009 |